HEPANOVA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hepanova.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Hepanova Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT04481594
- Locations
- 🇺🇸
Frontage Clinical Services, Inc, Secaucus, New Jersey, United States
News
No news found